HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Harry R Büller Selected Research

Antisense Oligonucleotides

1/2015Factor XI antisense oligonucleotide for prevention of venous thrombosis.
1/2015Factor XI antisense oligonucleotide for venous thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Harry R Büller Research Topics

Disease

76Venous Thromboembolism
01/2023 - 03/2002
59Hemorrhage
10/2023 - 07/2002
44Neoplasms (Cancer)
11/2023 - 09/2002
42Pulmonary Embolism
10/2023 - 02/2002
35Venous Thrombosis (Deep-Vein Thrombosis)
01/2023 - 04/2002
21Thrombosis (Thrombus)
01/2023 - 03/2002
6Stroke (Strokes)
12/2020 - 07/2011
6Atrial Fibrillation
12/2020 - 09/2005
6Thrombophilia
01/2019 - 05/2009
5Thromboembolism
06/2013 - 03/2005
4COVID-19
12/2021 - 10/2020
4Embolism (Embolus)
01/2019 - 02/2002
4Body Weight (Weight, Body)
02/2018 - 10/2003
4Cardiovascular Diseases (Cardiovascular Disease)
09/2015 - 05/2008
4Acute Coronary Syndrome
06/2013 - 03/2002
4Ischemic Stroke
07/2011 - 07/2002
4Myocardial Infarction
05/2011 - 07/2002
4Hyperhomocysteinemia
07/2008 - 10/2004
3Inflammation (Inflammations)
01/2022 - 10/2005
3Neoplasm Metastasis (Metastasis)
06/2021 - 04/2010
3Heart Failure
12/2020 - 05/2011
3Lung Neoplasms (Lung Cancer)
10/2020 - 11/2010
3Hypertension (High Blood Pressure)
01/2017 - 07/2009
3Thrombocytopenia (Thrombopenia)
01/2015 - 08/2011
3Atherosclerosis
07/2009 - 07/2002
3Sepsis (Septicemia)
10/2005 - 10/2002
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
12/2021 - 08/2018
2Infections
10/2020 - 11/2006
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2019 - 01/2015
2Diabetes Mellitus
09/2015 - 02/2012
2Right Ventricular Dysfunction
10/2013 - 08/2004
2Hemophilia A (Haemophilia)
02/2011 - 04/2005
2Protein S Deficiency (Deficiency, Protein S)
05/2009 - 03/2005
2Human Influenza (Influenza)
10/2007 - 11/2006
2Endotoxemia
07/2006 - 10/2002
2Activated Protein C Resistance (APC Resistance)
07/2006 - 02/2003
2Peripheral Arterial Disease
03/2003 - 07/2002
1Weight Loss (Weight Reduction)
12/2023

Drug/Important Bio-Agent (IBA)

54AnticoagulantsIBA
01/2023 - 02/2002
32fibrin fragment D (D-dimer)IBA
01/2023 - 02/2002
27Vitamin KFDA Link
01/2021 - 06/2003
26Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2023 - 03/2002
21Heparin (Liquaemin)FDA LinkGeneric
10/2020 - 03/2002
19Warfarin (Coumadin)FDA LinkGeneric
12/2020 - 06/2002
14edoxabanIBA
12/2021 - 10/2013
14Factor Xa InhibitorsIBA
01/2021 - 11/2002
12Enoxaparin (Lovenox)FDA LinkGeneric
01/2023 - 08/2003
9Prothrombin (Factor II)IBA
11/2023 - 07/2002
9Protein CIBA
08/2011 - 07/2003
9Factor VIII (Coagulation Factor VIII)IBA
02/2011 - 10/2002
8ThrombinFDA Link
01/2020 - 03/2002
7Dalteparin (Dalteparin Sodium)FDA Link
12/2021 - 03/2002
6factor V LeidenIBA
11/2023 - 03/2002
6AntithrombinsIBA
01/2019 - 10/2005
6RivaroxabanIBA
01/2016 - 03/2007
5Factor XI (Plasma Thromboplastin Antecedent)IBA
01/2023 - 10/2002
5Thromboplastin (Tissue Factor)IBA
01/2018 - 10/2002
5Fondaparinux (Arixtra)FDA Link
06/2013 - 11/2002
4Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
10/2023 - 10/2002
4ORALIT (ORS)IBA
12/2021 - 10/2017
4CreatinineIBA
10/2021 - 10/2013
4Factor Xa (Coagulation Factor Xa)IBA
01/2018 - 01/2012
4idraparinuxIBA
09/2015 - 03/2004
4Protein SIBA
08/2011 - 03/2005
4AntibodiesIBA
08/2011 - 03/2003
3apixabanIBA
01/2019 - 11/2016
3DabigatranFDA Link
11/2016 - 09/2007
3Thyroxine (Levothyroxine)FDA LinkGeneric
07/2016 - 06/2010
3AcenocoumarolIBA
09/2015 - 10/2005
3Brain Natriuretic Peptide (Natrecor)FDA Link
10/2013 - 11/2004
3Hormones (Hormone)IBA
02/2011 - 07/2004
3Nadroparin (Nadroparin Calcium)IBA
04/2010 - 04/2005
3Factor VIIa (Activated Factor VII)IBA
07/2006 - 01/2003
3recombinant FVIIa (rFVIIa)FDA Link
04/2005 - 11/2002
2Immunoglobulin G (IgG)IBA
06/2022 - 03/2003
2Hemoglobins (Hemoglobin)IBA
12/2021 - 10/2021
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019 - 04/2010
2Biomarkers (Surrogate Marker)IBA
01/2018 - 11/2004
2FibrinIBA
01/2018 - 11/2006
2Blood Coagulation Factors (Coagulation Factor)IBA
08/2016 - 09/2012
2Antisense OligonucleotidesIBA
01/2015 - 01/2015
2Adrenal Cortex Hormones (Corticosteroids)IBA
09/2013 - 05/2013
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2013 - 07/2004
2GlucocorticoidsIBA
05/2013 - 08/2009
2ProlactinIBA
09/2012 - 03/2011
2Glucose (Dextrose)FDA LinkGeneric
02/2012 - 02/2011
2Hemostatics (Antihemorrhagics)IBA
08/2009 - 07/2009
2Fibrinolytic Agents (Antithrombotic Agents)IBA
05/2008 - 05/2004
2HomocysteineIBA
08/2007 - 10/2004
1Peptide Hydrolases (Proteases)FDA Link
10/2023

Therapy/Procedure

27Therapeutics
06/2022 - 03/2002
9Drug Therapy (Chemotherapy)
12/2021 - 11/2010
5Duration of Therapy
01/2021 - 07/2003
3Knee Replacement Arthroplasty (Total Knee Replacement)
12/2021 - 02/2012
3Central Venous Catheters
07/2020 - 09/2003
2Hip Replacement Arthroplasty (Total Hip Replacement)
09/2007 - 07/2002
2Continuous Renal Replacement Therapy
07/2006 - 07/2003
2Thrombolytic Therapy
11/2004 - 09/2004
2Aftercare (After-Treatment)
06/2003 - 03/2002
1Carbohydrate-Restricted Diet (Low Carbohydrate Diet)
12/2023